08:22 AM EDT, 08/07/2024 (MT Newswires) -- The Brink's Co. (BCO) reported Q2 non-GAAP earnings Wednesday of $1.67 per share, up from $1.27 a year earlier. Analysts polled by Capital IQ expected $1.47. Revenue for the quarter ended June 30 was $1.25 billion, compared with $1.22 billion a year earlier. Analysts surveyed by Capital IQ expected $1.26 billion. The company...

LONDON (Reuters) - U.S. patients are staying on Novo Nordisk's Wegovy weight-loss medication for around six months, an executive said on Wednesday, adding that the company is confident that over time as shortages ease that will increase to 12 months. Doug Langa, Novo's head of North America operations, was speaking on a call with analysts after the company trimmed its...

08:23 AM EDT, 08/07/2024 (MT Newswires) -- Vertex (VERX) reported Q2 non-GAAP earnings Wednesday of $0.15 per diluted share, compared with $0.08 a year earlier. Analysts surveyed by Capital IQ expected $0.13. Revenue for the quarter ended June 30 was $161.1 million, compared with $139.7 million a year earlier. Analysts surveyed by Capital IQ expected $160.7 million. The tax compliance...

Aug 7 (Reuters) - Charles River Laboratories ( CRL ) trimmed its annual forecast on Thursday, as it no longer expects demand for its drug discovery and development services to improve in the second half of the year, sending its shares down 15% in premarket trading. The contract research firm also said its board has approved a new stock repurchase...